Comparative studies of the ethynyl estrogens used in oral contraceptives: effects with and without progestational agents on plasma androstenedione, testosterone, and testosterone binding in humans, baboons, and beagles.
The effects of ethynylestradiol or mestranol given in cyclic fashion, with and without a progestational compound (norethindrone acetate, dl-norgestrel, or megestrol acetate), on plasma androgens and their binding were examined in adult women, female baboons, and beagles. The two estrogens are equivalent in their effect, and there were essentially no dose-related differences over the range examined. In human subjects, the estrogens increased total testosterone and testosterone binding, and decreased free testosterone. In baboons, estrogen produced a transient decrease in total testosterone and an increase in binding. The levels of progestational agents used did not affect total testosterone in humans, as is commonly observed with commercial agents, but did decrease it in baboons. Percentage binding was decreased in both species by the 19-nor compounds, but not by megestrol. Androstenedione levels were unaffected in human subjects, but effects of both estrogens and progestins were seen in baboons. Because of the very low levels of androgens in female beagles, this species did not lend itself well to a study of this kind. However, an increase in testosterone binding was induced by estrogen even in the absence of testosterone/estrogen-binding globulin.
D000735:Androstenedione / Q000097:blood*; D000818:Animals; D003276:Contraceptives, Oral / Q000494:pharmacology; D004285:Dogs; D004347:Drug Interactions; D045166:Estradiol Congeners / Q000494:pharmacology*; D004997:Ethinyl Estradiol / Q000494:pharmacology; D005260:Female; D000882:Haplorhini; D006801:Humans; D007434:Intrauterine Devices; D008535:Megestrol / Q000494:pharmacology; D008656:Mestranol / Q000494:pharmacology; D009640:Norethindrone / Q000494:pharmacology; D009644:Norgestrel / Q000494:pharmacology; D010215:Papio; D045167:Progesterone Congeners / Q000494:pharmacology*; D013045:Species Specificity; D013739:Testosterone / Q000097:blood / Q000378:metabolism*; D013810:Therapeutic Equivalency
D003276:Contraceptives, Oral; D045166:Estradiol Congeners; D045167:Progesterone Congeners; D009644:Norgestrel; D013739:Testosterone; D000735:Androstenedione; D004997:Ethinyl Estradiol; D008656:Mestranol; D008535:Megestrol; D009640:Norethindrone